Modular Platforms to Advance Gene Therapy Development
Andelyn’s platform solutions are designed to support the evolving needs of cell and gene therapies across modalities, stages, and complexities. From early research through clinical and commercial readiness, these platforms bring together scientific expertise, flexible process development, and scalable manufacturing to help teams move forward with clarity and confidence.
AAV Curator® Platform
Built on data and configurability, the AAV Curator® platform tailors the manufacturing process to your program’s specific needs to optimize yields and performance. It accounts for key variables across upstream, downstream, and fill-and-finish, including materials, testing, and release parameters.
LVV Curator® Platform
Our LVV Curator® Platform uses the same proven modular approach as our AAV platform, standardized where it matters, flexible where it counts, supporting efficient development and manufacturing to meet each client’s needs.
Optimization-By-Design™
Industrializing Gene Therapy Processes with a Reductionist, Holistic and Systematic Optimization Methodology Approach
Consistency in productivity and quality are evaluated at each stage of development and measured with enabling technologies.
Benefits of Our Platform Approach
Reduced Spending on Optimization
High Productivity and % Full Capsids driving production costs down
No MCB Generation Costs
No Tech Transfer Costs
No PreClinical/clinical Licensing Fees
Reduced time spent on opTimization
Off the Shelf (OTS) plasmids readily avaIlable
No MCB generatIon time
Supply Chain Already Established
NO TECH TRANSFER/DOCUMENTATION TIME
DMFs filed for Andelyn’s platform
Same equipment in non-GMP & GMP
Same quality systems
Integrated teams in Preclinical & Clinical
Does your program use another vector rather than AAV?
Check out our Tech Transfer capabilities.